Vitamin D may be used to reduce the risk of immune checkpoint inhibitor-related colitis, as well as ulcerative colitis and graft-vs-host disease.
Research findings from ESMO confirm that patients with cancer can improve their symptoms of CRF if they “avoid inactivity”; in addition, greater use of supportive care can also help.
A retrospective study of CMV-seropositive adults receiving allogeneic HCT and CMV-seronegative HLA-matched sibling donors found that vancomycin exposure before HCT increased the risk for CMV reactivation.
Researchers evaluated the prevalence, level, and impact on QOL of patient-reported urinary incontinence at baseline and after 3 months of systemic therapy.
Patients with chronic lymphocytic leukemia who are treated with ibrutinib may have a higher incidence of atrial fibrillation than previously thought.
In this patient case, significant neurological adverse effects associated with nelarabine were noted at 30 days following initiation of therapy.
Black, Hispanic patients less likely to receive recommended imaging at time of diagnosis of NSCLC.
The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.
Odds of developing ICI colitis significantly reduced with vitamin D use in patients with melanoma.
A discussion on the genetic influence of single nucleotide polymorphisms on cancer pain and their potential to assist pain management in patients with cancer.